1 Background Lung cancer is a malignancy with the highest mortality rate, with no treatment method that could effectively prolong the long-term survival rate of lung cancer patients (Sung et al., 2021)
Common research protocols cited in the peptide community use 1 to 2 mg, 3 to 5 times weekly, over 8 to 12-week cycles
S.MobleyM.et al
Preferred Injection Sites : Lower abdomen (2-3 inches from navel) Upper thighs (outer quadrant) Upper arms (posterior aspect) Rotate injection sites to prevent lipodystrophy Injection Equipment : 30-31 gauge insulin syringes 0.5-1ml syringe capacity 12.7mm (1/2 inch) needle length Reconstitution Protocol AOD 9604 typically requires reconstitution from lyophilized powder: Use bacteriostatic water (0.9% benzyl alcohol) Add 2ml bacteriostatic water to 5mg vial Results in 2.5mg/ml concentration Gently swirl until completely dissolved Store reconstituted solution refrigerated Storage Requirements Unreconstituted : Room temperature, protect from light Reconstituted : Refrigerate at 2-8C (36-46F) Stability : Use within 28 days of reconstitution Transport : Keep cool during travel, avoid freezing Optimal Timing and Cycling Strategies Timing for Maximum Effectiveness Morning Administration : Primary recommendation for single daily dosing
You might see tiny pinpoint marks where the needle entered this is completely normal
Oncogene-mediated ROS production has been associated with (i) Ras-activated signaling altering the metabolism of the mitochondrial potential and increasing the activity of NADPH oxidases 2 and 4 (NOX2 and NOX4), (ii) antiapoptotic B-cell lymphoma 2 (Bcl-2) altering the mitochondrial potential, (iii) signal transducer and activator of transcription 3 (STAT3) altering mitochondrial metabolism and activating NADPH 4 (NOX4), and (iv) the multipurpose oncogenic transcription factor MYC (a cancer of the myelocytes, myelocytoma), which downregulates mitochondrial mass and biogenesis (Hayes et al
